Phase III trials now include 42% more procedures and 37% more endpoints compared to a decade ago A significant portion of collected data is not directly tied to primary endpoints, adding operational burden without improving outcomes According to Tufts Center for the Study of Drug Development, complexity continues to increase across all phases, affecting timelines, costs, and site workload For sponsors, this translates into longer start-up timelines, more amendments, and increased execution risk
Many people associate specific colors with certain medications, which can aid in preventing mix-ups
These can include nausea, vomiting, and diarrhea, but they typically diminish over time as the body adjusts
Our experts are here to help!
Made in the UK and produced in premises that operate to stringent pharmaceutical standards of GMP